UTHR - United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
2024-05-01 14:46:13 ET
United Therapeutics Corporation (UTHR)
Q1 2024 Earnings Conference Call
May 1, 2024 09:00 AM ET
Company Participants
Dewey Steadman - Head of Investor Relations
Martine Rothblatt - Chairperson and Chief Executive Officer
Michael Benkowitz - President and Chief Operating Officer
James Edgemond - Chief Financial Officer and Treasurer
Leigh Peterson - Executive Vice President-Product Development and Xenotransplantation
Conference Call Participants
Terence Flynn - Morgan Stanley
Roanna Ruiz - Leerink
Ash Verma - UBS
Joseph Thome - TD Cowen
Presentation
Operator
Good morning and welcome to the United Therapeutics Corporation First Quarter 2024 Earnings Webcast. My name is Danielle and I will be your conference operator today. All participants on the call portion of this webcast will be in listen-only mode until the question-and-answer portion of the earnings call. [Operator Instructions] Please note this call is being recorded.
I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics....
United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript